An MVA Vector Expressing HIV-1 Envelope under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design

Highly attenuated poxviral vectors, such as modified vaccinia virus ankara (MVA), are promising vaccine candidates against several infectious diseases. One of the approaches developed to enhance the immunogenicity of poxvirus vectors is increasing the promoter strength and accelerating during infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez, Patricia, Marín, María Q., Lázaro-Frías, Adrián, Sorzano, Carlos Óscar S., Di Pilato, Mauro, Gómez, Carmen E., Esteban, Mariano, García-Arriaza, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963416/
https://www.ncbi.nlm.nih.gov/pubmed/31817622
http://dx.doi.org/10.3390/vaccines7040208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963416/
https://www.ncbi.nlm.nih.gov/pubmed/31817622
http://dx.doi.org/10.3390/vaccines7040208

Ejemplares similares